First use

The first successful use of the artificial cell in routine clinical applications is hemoperfusion . After initial clinical trials for poisoning, kidney failure, and liver failure , it is now in routine clinical use, especially for the treatment of suicidal or accidental poisoning from medications . It is also being used in combination with the hybrid artificial liver in clinical trials.